590 filings
Page 13 of 30
8-K/A
3qt0duvz8m7x42g3fxn
12 Jun 20
Financial Statements and Exhibits
4:31pm
CORRESP
uibtlzer72a65c
12 Jun 20
Correspondence with SEC
12:00am
UPLOAD
ffsbsk6ah1n0eot
11 Jun 20
Letter from SEC
12:00am
UPLOAD
qwfzo2g3b
3 Jun 20
Letter from SEC
12:00am
DEFA14A
631bw 16g6vl6nb
2 Jun 20
Additional proxy soliciting materials
7:30am
8-K
qf19kbrf1tvhlusrcge
27 May 20
Other Events
4:31pm
D
lw6b23ku
15 May 20
$22.57M in equity / options, sold $22.57M, 149 investors
1:22pm
CORRESP
d89nczsdobn
15 May 20
Correspondence with SEC
12:00am
SC 13D
ce64m9rpmxspj gznz0
14 May 20
9 METERS BIOPHARMA / OrbiMed Israel BioFund GP Limited Partnership ownership change
5:25pm
UPLOAD
r1bdcmq3
13 May 20
Letter from SEC
12:00am
8-K
tm95a7h2zy792fj ynx3
11 May 20
9 Meters Biopharma, Inc Receives Thorough QT Study Waiver by FDA for Larazotide Being Studied for Celiac Disease
4:36pm
8-K
iiuazsnpwrk3rjksm
8 May 20
9 Meters Biopharma, Inc Announces the Closing of Naia Rare Diseases Acquisition
4:15pm
8-K
62cgp3h
5 May 20
9 Meters Biopharma Hosting Research & Development Day
4:33pm
4
3hp20ektdzp468cdd
5 May 20
Change in insider ownership
4:20pm
4
gbrif
5 May 20
INNOVATE BIOPHARMACEUTICALS / Nissim Darvish ownership change
4:18pm
4
9eg3ayyo
4 May 20
INNOVATE BIOPHARMACEUTICALS / Nissim Darvish ownership change
7:40pm